Pyrimidine Intermediates for H4 Receptor Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing benzoimidazol-2-yl pyrimidines are inefficient in producing compounds with specific structures and functionalities needed for modulating H4 receptor activity, which is crucial for treating conditions like allergy, asthma, and autoimmune diseases.
Innovation Solution
The development of compounds according to Formula (VI) and Formula (IV) structures, involving reactions between specific compounds and their salts under controlled conditions, using coupling agents like PyBOP and EDC HCl, to produce compounds useful as intermediates for further conversion into active pharmaceutical forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods are used for preparing benzoimidazol-2-yl pyrimidines, then the process is simpler, but the efficiency and ability to produce compounds with specific structures needed for H4 receptor modulation is insufficient
Solution Approach 1:
The patent divides the synthesis into distinct modular stages: preparing substituted pyrimidine-5-carboxylic acids with specific R1, R2, and R3 substituents, converting them to acid chlorides or activated esters, and finally coupling with substituted anilines. This segmentation allows each step to be optimized independently for efficiency while maintaining overall process manageability.
Solution Approach 2:
The patent employs preliminary protection of amino groups and carboxylic acid groups before the main coupling reaction. Protecting groups are installed in advance to prevent unwanted side reactions, then removed after the coupling is complete. This preliminary action ensures high efficiency in the main transformation step by eliminating competing reactions.
2Reliability
If specific structured intermediates are synthesized for H4 receptor modulation, then therapeutic effectiveness is improved, but the manufacturing complexity increases
Solution Approach 1:
The patent introduces specific substituents at defined positions on the pyrimidine ring (R1 at position 4, R2 at positions 2 and 6, R3 at position 5) to achieve the precise molecular structure required for H4 receptor modulation. This local modification of specific ring positions provides the necessary therapeutic effectiveness while maintaining a systematic approach to synthesis.
Solution Approach 2:
The patent systematically varies substituent parameters (different alkyl groups, halogens, and protecting groups) at specific positions on the pyrimidine ring to optimize both biological activity and synthetic accessibility. By changing these molecular parameters in a controlled manner, the patent achieves reliable therapeutic compounds while maintaining reasonable manufacturing complexity.
Data Source
AI summary
The present invention relates to certain intermediates useful in the preparation of certain benzoimidazol-2-yl pyrimidines and processes for preparing them. In particular, the present invention relates to various 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides as useful intermediates in the preparation of compounds including